Cytopathology

Decreased testing could lead to STI surge

Screening and testing for sexually transmitted infections (STIs) in the US decreased by 63% for men and 59% for women during the early months of the pandemic.

Rise of the resistance

Kip Heath, Lead Healthcare Scientist, Public Engagement Lead and stand-up comedian, introduces a project to raise public awareness of antimicrobial resistance.

My lab: a whole new approach to assessment

Leslie Ramos, Cellular Pathology Quality Manager, gives a guided tour of her lab and talks through a recent virtual UKAS assessment.

Sponge on a string pill

A “sponge on a string” pill test can identify 10 times more people with Barrett’s oesophagus than the usual GP route, finds new research.

Here to help: New cytology portfolios

This month we are outlining a new launch to better support the training and development of the biomedical scientist workforce.

"Disasters lead to reductions in cancer screening"

Cervical cancer screening rates in Japan were significantly affected in the years following the devastating Great East Japan Earthquake of 2011.

Cervical screening in Moldova

Lead Biomedical Scientist and British Association for Cytopathology Executive Committee Member Hedley Glencross introduces a project to improve the outdated cervical screening programme in the Republic of Moldova.

Avoidable cancer delays

One in four cancer patients experienced a delay to their diagnosis that could have been avoided, according to a new study by Cancer Research UK.

Diagnosing brain cancer

A blood test which could help to accelerate the diagnosis of brain cancer has been developed.

November news in numbers

A breakdown of science news this month, in numbers.

New cancer-driving mutation

Scientists have discovered a novel cancer-driving mutation in the vast non-coding regions of the human cancer genome, also known as the “dark matter” of human cancer DNA.

Top